OncoTherapy Science

Business Services · Japan · 11-50 Employees

View Company Info for Free

Overview

Headquarters

1-2 Higashida-cho Kawasaki-ku, Kawasaki-...

Phone Number

+81 442016429

Revenue

$5.7 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About OncoTherapy Science

OncoTherapy Science, Inc. researches and develops anti-cancer medicines and therapies in Japan. Its clinical development product pipeline includes small-molecule drugs, such as OTS167, a maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I clinical trials for the treatment of breast cancer; and OTS964, a T-LAK cell-originated protein kinase inhibitor for the treatment of various cancer diseases. The company's clinical development product pipeline also comprise cancer- specific peptide vaccines, including S-588410, which is in Phase III clinical trials for the treatment esophageal cancer, as well as in Phase II clinical trials for the treatment of bladder cancer; S-488210 that is in Phase I/II clinical trials for the treatment of head and neck cancer; and S-588210, which is in Phase I clinical trials for the treatment of solid tumor. In addition, it is developing antibody drugs consistRead more
OncoTherapy Science's Social MediaPopular SearchesOncoTherapy Science IncOncoTherapy ScienceOncoTherapy Science Inc (4564)OncoTherapy Science Inc, 4564オンコセラピー・サイエンス(株)SIC Code 87,873NAICS Code 54,541Show more

OncoTherapy Science Org Chart

PhoneEmail
KT
Japan flag for contact location.

President

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is OncoTherapy Science your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

OncoTherapy Science is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

OncoTherapy Science is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about OncoTherapy Science.

OncoTherapy Science Tech Stack

A closer look at the technologies used by OncoTherapy Science

Top Business Services Companies

Frequently Asked Questions Regarding OncoTherapy Science

What is OncoTherapy Science's official website?
OncoTherapy Science's official website is www.oncotherapy.co.jp
What is OncoTherapy Science's Revenue?
OncoTherapy Science's revenue is $5.7 Million
What is OncoTherapy Science's SIC code?
OncoTherapy Science's SIC: 87,873
What is OncoTherapy Science's NAICS code?
OncoTherapy Science's NAICS: 54,541
How many employees does OncoTherapy Science have?
OncoTherapy Science has 11-50 employees
What industry does OncoTherapy Science belong to?
OncoTherapy Science is in the industry of: Business Services, Research & Development
What technology does OncoTherapy Science use?
Some of the popular technologies that OncoTherapy Science uses are: WordPress.org, PHP, Google Universal Analytics, Microsoft 365
How do I contact OncoTherapy Science?
OncoTherapy Science contact info: Phone number: +81 442016429 Website: www.oncotherapy.co.jp
What does OncoTherapy Science do?

OncoTherapy Science, Inc. researches and develops anti-cancer medicines and therapies in Japan. Its clinical development product pipeline includes small-molecule drugs, such as OTS167, a maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I clinica... l trials for the treatment of breast cancer; and OTS964, a T-LAK cell-originated protein kinase inhibitor for the treatment of various cancer diseases. The company's clinical development product pipeline also comprise cancer- specific peptide vaccines, including S-588410, which is in Phase III clinical trials for the treatment esophageal cancer, as well as in Phase II clinical trials for the treatment of bladder cancer; S-488210 that is in Phase I/II clinical trials for the treatment of head and neck cancer; and S-588210, which is in Phase I clinical trials for the treatment of solid tumor. In addition, it is developing antibody drugs consisting of OTSA101, which is in Phase I clinical trials for synovial sarcoma; and KHK6640, an anti-amyloid beta peptide antibody that is Phase I clinical trials for Alzheimer's disease. Further, the company provides contract analysis services. OncoTherapy Science, Inc. was founded in 2001 and is headquartered in Kawasaki, Japan.Read More

What are OncoTherapy Science social media links?
OncoTherapy Science Linkedin page
Is OncoTherapy Science a public company?
OncoTherapy Science is private company therefore does not currently have an official ticker symbol
See more information about OncoTherapy Science

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.